Oligodendroglioma Medication

Updated: Oct 01, 2019
  • Author: ABM Salah Uddin, MD; Chief Editor: Stephen A Berman, MD, PhD, MBA  more...
  • Print

Medication Summary

The standard chemotherapeutic treatment for oligodendrogliomas is combination chemotherapy with PCV. While modifications of the timing and dosage of this regimen (increasing dose, decreasing time interval to every 6 wk), are beyond the scope of this article, interested readers can review the references cited in Bibliography. Physicians prescribing chemotherapy should be aware of the treatment regimens and monitoring required. PCV chemotherapy is administered every 6 weeks or 8 weeks for a total of 6 cycles. If the treatment should fail, radiation therapy, other clinical trials for recurrent gliomas, or other drugs may be considered.


PCV chemotherapy

Class Summary

This combination of agents inhibits cell growth and differentiation.

Procarbazine, lomustine (CCNU), vincristine

Oral chemotherapy drugs administered in combination (PCV) on a specific chemotherapeutic schedule.